BIOMAT Database Logo BIOMAT Database Logo

Double cardiomyopathy: coexistent cardiac amyloidosis and hypertrophic obstructive cardiomyopathy. 1993

W P Buchanan, and S W Schreiter, and F R Kahl, and P E Lantz, and H B Cheek, and J Risley, and A M Nomeir
Department of Medicine, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC 27157.

A combination of hypertrophic obstructive cardiomyopathy (HOCM) and cardiac amyloidosis in the same patient is very rare. Clinical diagnosis could be extremely difficult and may require myocardial biopsy. We are reporting a patient with this combination who was referred to our institution because of features of HOCM based on clinical, echocardiographic and Doppler criteria. Cardiac amyloidosis was only recognized after myocardial biopsy that failed to reveal evidence of HOCM. Only after the patient expired from severe, intractable heart failure did the autopsy findings confirm the association of HOCM. We believe that the combination of the two cardiomyopathic processes is very rare and makes treatment extremely difficult.

UI MeSH Term Description Entries
D009202 Cardiomyopathies A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS). Myocardial Disease,Myocardial Diseases,Myocardial Diseases, Primary,Myocardial Diseases, Secondary,Myocardiopathies,Primary Myocardial Disease,Cardiomyopathies, Primary,Cardiomyopathies, Secondary,Primary Myocardial Diseases,Secondary Myocardial Diseases,Cardiomyopathy,Cardiomyopathy, Primary,Cardiomyopathy, Secondary,Disease, Myocardial,Disease, Primary Myocardial,Disease, Secondary Myocardial,Diseases, Myocardial,Diseases, Primary Myocardial,Diseases, Secondary Myocardial,Myocardial Disease, Primary,Myocardial Disease, Secondary,Myocardiopathy,Primary Cardiomyopathies,Primary Cardiomyopathy,Secondary Cardiomyopathies,Secondary Cardiomyopathy,Secondary Myocardial Disease
D002312 Cardiomyopathy, Hypertrophic A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY). Cardiomyopathy, Hypertrophic Obstructive,Cardiomyopathies, Hypertrophic,Cardiomyopathies, Hypertrophic Obstructive,Hypertrophic Cardiomyopathies,Hypertrophic Cardiomyopathy,Hypertrophic Obstructive Cardiomyopathies,Hypertrophic Obstructive Cardiomyopathy,Obstructive Cardiomyopathies, Hypertrophic,Obstructive Cardiomyopathy, Hypertrophic
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000686 Amyloidosis A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits. Amyloidoses

Related Publications

W P Buchanan, and S W Schreiter, and F R Kahl, and P E Lantz, and H B Cheek, and J Risley, and A M Nomeir
Cardiac AA amyloidosis in a patient with obstructive hypertrophic cardiomyopathy.
January 2020, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology,
W P Buchanan, and S W Schreiter, and F R Kahl, and P E Lantz, and H B Cheek, and J Risley, and A M Nomeir
Cardiac amyloidosis mimicking hypertrophic cardiomyopathy.
January 1986, Acta medica Scandinavica,
W P Buchanan, and S W Schreiter, and F R Kahl, and P E Lantz, and H B Cheek, and J Risley, and A M Nomeir
Cardiac amyloidosis simulating hypertrophic cardiomyopathy.
March 1984, The American journal of cardiology,
W P Buchanan, and S W Schreiter, and F R Kahl, and P E Lantz, and H B Cheek, and J Risley, and A M Nomeir
Hypertrophic cardiomyopathy complicated with cardiac amyloidosis.
August 2000, Internal medicine (Tokyo, Japan),
W P Buchanan, and S W Schreiter, and F R Kahl, and P E Lantz, and H B Cheek, and J Risley, and A M Nomeir
Cardiac amyloidosis presenting as pseudo-hypertrophic cardiomyopathy.
January 2004, Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners,
W P Buchanan, and S W Schreiter, and F R Kahl, and P E Lantz, and H B Cheek, and J Risley, and A M Nomeir
Cardiac amyloidosis and hypertrophic cardiomyopathy: A dangerous liaison.
January 2013, Global cardiology science & practice,
W P Buchanan, and S W Schreiter, and F R Kahl, and P E Lantz, and H B Cheek, and J Risley, and A M Nomeir
Cardiac impulse in hypertrophic obstructive cardiomyopathy.
May 1966, British heart journal,
W P Buchanan, and S W Schreiter, and F R Kahl, and P E Lantz, and H B Cheek, and J Risley, and A M Nomeir
Results of operation for coexistent obstructive hypertrophic cardiomyopathy and coronary artery disease.
June 1989, Journal of the American College of Cardiology,
W P Buchanan, and S W Schreiter, and F R Kahl, and P E Lantz, and H B Cheek, and J Risley, and A M Nomeir
Transthyretin Amyloidosis Mimicking Obstructive Hypertrophic Cardiomyopathy: A Great Imitator.
May 2019, Heart, lung & circulation,
W P Buchanan, and S W Schreiter, and F R Kahl, and P E Lantz, and H B Cheek, and J Risley, and A M Nomeir
Double trouble: hypertrophic cardiomyopathy coexistent with malignant anomalous right coronary artery.
March 2014, BMJ case reports,
Copied contents to your clipboard!